RBC Capital Upgrades PharMerica (PMC) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts PMC Hot Sheet
Price: $29.25 --0%
Rating Summary:
3 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Rating Summary:
3 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Join SI Premium – FREE
RBC Capital upgraded PharMerica (NYSE: PMC) from Sector Perform to Outperform, price target raised from $13 to $15.
For an analyst ratings summary and ratings history on PharMerica click here. For more ratings news on PharMerica click here.
Shares of PharMerica closed at $11.51 yesterday.
For an analyst ratings summary and ratings history on PharMerica click here. For more ratings news on PharMerica click here.
Shares of PharMerica closed at $11.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Chow Tai Fook Jewellery Group Ltd. (1929:HK) (CJEWF) to Buy
- Jefferies Upgrades Rivian (RIVN) to Buy, '3Q26 - Acceleration'
- Goldman Sachs Downgrades Luk Fook Holdings International Ltd. (590:HK) (LKFLF) to Sell
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
